Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

HCV screening of pregnant and nonpregnant women in the US are increasing but remain suboptimal suggesting the need for ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing ...

We came across a bullish thesis on Atea Pharmaceuticals, Inc. (AVIR) on Substack by Turtles Research. In this article, we ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

Please provide your email address to receive an email when new articles are posted on . HCV screening increased after guidelines updated to screen all adults and during each pregnancy. Screening ...

Maternal hepatitis C virus (HCV) RNA titer > 10⁶ International Units (IU)/mL and antepartum bleeding are key predictors of perinatal transmission, with the risk ranging from 1.5% to 28.5%.

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

HEPATITIS C Virus (HCV) is one of the most pressing public health challenges in Pakistan. More than 10 million people are already infected by it, and 450,000 acquire the infection each year.

Compared with enhanced usual care, peer-assisted telemedicine hepatitis C virus (HCV) treatment significantly increased HCV treatment initiation and viral clearance. Hepatitis C virus (HCV ...

Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Program for Hepatitis C Virus (HCV)Patient Enrollment in Global Phase 3 HCV ...